AVADEL PHARMACEUTICALS
Avadel Pharmaceuticals plc (Nasdaq:AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and through in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (CNS) / sleep, and hospital markets. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.
AVADEL PHARMACEUTICALS
Industry:
Biotechnology Information Technology Manufacturing Pharmaceutical
Founded:
1990-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.avadel.com
Total Employee:
101+
Status:
Active
Contact:
(636) 449-1830
Email Addresses:
[email protected]
Total Funding:
190 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon IPv6 Organization Schema COVID-19 Amazon Route 53 Ruby On Rails Token Amazon S3 CDN OpenResty Microsoft Azure ContactPoint Schema
Similar Organizations
EXCELLER
EXCELLER is a business development company focusing on life science technology.
Ferring Pharmaceuticals
Ferring is a biopharmaceutical company dedicated to the development of innovative treatments that make a real difference in people’s lives.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Current Employees Featured
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Avadel Pharmaceuticals
RTW Investments
RTW Investments investment in Post-IPO Equity - Avadel Pharmaceuticals
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Avadel Pharmaceuticals
Acuta Capital Partners
Acuta Capital Partners investment in Post-IPO Equity - Avadel Pharmaceuticals
KVP Capital
KVP Capital investment in Post-IPO Equity - Avadel Pharmaceuticals
Avoro Capital Advisors
Avoro Capital Advisors investment in Post-IPO Equity - Avadel Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Avadel Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-14 | Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer |
Official Site Inspections
http://www.avadel.com Semrush global rank: 10.12 M Semrush visits lastest month: 257
- Host name: a11472d5bbcc1c369.awsglobalaccelerator.com
- IP address: 99.83.129.68
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Avadel Pharmaceuticals"
Avadel Pharmaceuticals – Transforming Treatment Options for …
At Avadel, our core values foster an atmosphere of innovation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development …See details»
Careers & Culture - Avadel Pharmaceuticals
At Avadel, the way we work is as important as the results we achieve. Our global organization fosters an entrepreneurial environment, where purpose, innovation, integrity, and collaboration come together to transform medicines to transform …See details»
Avadel Pharmaceuticals - Wikipedia
Avadel Pharmaceuticals plc, is a specialty pharmaceutical company.Avadel markets products in the hospital and primary care spaces. The Company is headquartered in Dublin, Ireland with …See details»
Avadel Pharmaceuticals PLC - LinkedIn
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. ... Discover more about this global initiative by the World Health Organization and how ...See details»
Avadel Pharmaceuticals - Crunchbase Company Profile …
Avadel Pharmaceuticals plc (Nasdaq:AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing …See details»
Avadel Pharmaceuticals Org Chart + Executive Team - The Official …
Organizational Chart of Avadel Pharmaceuticals. Avadel Pharmaceuticals Org Chart www.avadel.com. has 19 executives +33 472 783 434; Add an executive. Avadel …See details»
Avadel - Crunchbase Company Profile & Funding
Organization. Avadel . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Avadel provides business development services. Fort Worth, …See details»
Avadel - The Org
Avadel. 1 follower Avadel is a biopharmaceutical company focused on transforming medicines to transform lives. ...See details»
Avadel Pharmaceuticals - Funding, Financials, Valuation & Investors
Avadel is a biopharmaceutical company focused on transforming medicines to transform lives. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Avadel Pharmaceuticals Announces Changes to Management …
Jan 3, 2019 Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy …See details»
Avadel Pharmaceuticals PlcExecutive & Employee Information
The following section provides information on Avadel Pharmaceuticals Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight …See details»
Avadel Announces Grant of Inducement Awards Under Nasdaq …
1 day ago DUBLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today …See details»
Avadel Pharmaceuticals Selects TCG for Head of Talent
Oct 15, 2024 ST. LOUIS, MISSOURI – Avadel Pharmaceuticals, a dynamic biopharmaceutical company driven by a mission to transform medicines and improve lives, has selected The …See details»
Avadel Pharmaceuticals - Craft
Oct 29, 2024 Avadel Pharmaceuticals PLC is a specialty pharmaceutical company engaged in identifying, developing, and commercializing niche branded pharmaceutical products. The …See details»
Avadel Pharmaceuticals to Provide a Corporate Update and Report …
DUBLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced …See details»
Avadel Pharmaceuticals
Apr 21, 2025 Avadel was founded in January 2001 through a merger of Neo Pharm International and Laboratoires Delagrange. The company identified its primary focus early on in the …See details»
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports …
Mar 3, 2025 Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results PDF Version -- LUMRYZ™ generated $50.4 million in sales in the fourth quarter, up 158% year-over-year, taking the full-year total to $169.1 million , in line with preliminary results published January 8See details»
Our Product for Narcolepsy - Avadel
According to the National Organization for Rare Disorders, it's estimated that 1 in every 2,000 people are living with narcolepsy in the U.S. For people living with narcolepsy, the lines …See details»
What is Avadel? Company Culture, Mission, Values | Glassdoor
See what employees say it's like to work at Avadel. Salaries, reviews, and more - all posted by employees working at Avadel.See details»
Press Releases - Avadel Pharmaceuticals PLC
Mar 5, 2025 DUBLIN , Jan. 06, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focu... 01/03/25 Avadel Pharmaceuticals to Provide a Corporate …See details»